Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
Publication Type: Editorial & Opinion
Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 964-967.
Abstract: SARS-CoV-2 has caused the COVID-19 pandemic since early 2020. As of January 2022, the worldwide spreading of SARS-CoV-2 leads to approximately 0.35 billion of human infections and five millions of deaths. Current vaccination is one of the effective way...
Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
Publication Type: Academic Journal
Source(s): MBio [mBio] 2022 Apr 26; Vol. 13 (2), pp. e0013522. Date of Electronic Publication: 2022 Mar 15.
Abstract: At the time of this writing, December 2021, potential emergence of vaccine escape variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a grave global concern. The interface between the receptor-binding domain (RBD) of SARS-CoV-2 ...
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection.
Publication Type: Academic Journal
Source(s): Vaccines; Apr2023, Vol. 11 Issue 4, p773, 8p
Abstract: Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for in...
Saliva and Plasma Neutralizing Activity Induced by the Administration of a Third bnt162b2 Vaccine Dose.
Publication Type: Academic Journal
Source(s): International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 22, p14341. 16p.
Abstract: The BNT162b2 vaccine induces neutralizing activity (NA) in serum, but no data are available on whether a third-dose activates specific-immunity within the oral mucosa, representing the primary route of viral-entry. To carefully address this issue, we i...
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.
Publication Type: Academic Journal
Source(s): Nature Communications; 10/23/2022, Vol. 13 Issue 1, p1-15, 15p
Abstract: Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, ...
Worldwide vaccine inequality threatens to unleash the next COVID-19 variant.
Publication Type: Academic Journal
Source(s): International Journal of Infectious Diseases. Oct2022, Vol. 123, p133-135. 3p.
Abstract: • Significant inequities remain in COVID-19 vaccine distribution and vaccination rates worldwide. • Worldwide COVID-19 vaccine distribution is complicated by supply, logistics, and vaccine hesitancy. • Recent COVID-19 variants have emerged from regions...
COVID-19 Vaccine Effectiveness against Omicron Variant among Underage Subjects: The Veneto Region's Experience.
Publication Type: Academic Journal
Source(s): Vaccines; Aug2022, Vol. 10 Issue 8, p1362-1362, 14p
Abstract: Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for in...
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 5/17/2022, Vol. 13, p1-10, 10p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.
Publication Type: Academic Journal
Source(s): Frontiers in Immunology; 4/29/2022, Vol. 13, p1-13, 13p
Abstract: Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, dow...
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant.
Publication Type: Academic Journal
Source(s): Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2161-2168.
Abstract: Background: The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may be less effective against the Omicron variant than against earlier variants. With recent resurgence of SARS-CoV-2 cases, the role of booster doses of the ...